This chapter explores the role of pharmacy benefit managers (PBMs) in the US prescription drug market, discussing their design of drug coverage, negotiation of discounts, and the inefficiencies in the supply chain. It also tackles the lack of competition in the PBM market and proposes ending insurance coverage for low-cost generic drugs to save costs and invest more in healthcare.
Bloomberg News Rates Reporter Michael MacKenzie and Bloomberg News Chief Correspondent for Global Macro Markets Liz McCormick explain how in a year in which little has gone right in the US bond market, November turned out to be a month for the record books. Ge Bai, Professor of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, talks about middlemen pocketing 70% of Medicare spending on widely used generic drugs. Bloomberg Businessweek Editor Joel Weber, Businessweek Technology Editor Joshua Brustein and Bloomberg News AI Reporter Rachel Metz share the details of the Businessweek Magazine story Sam Altman Won the War for OpenAI. Now Comes Winning the Peace. And we Drive to the Close with John Augustine, CIO of Huntington Private Bank.
Hosts: Carol Massar and Jess Menton. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.